Robert Heimer1, Mawuena Binka1, Stephen Koester2, Jean-Paul C Grund3,4,5, Amisha Patel1, Elijah Paintsil1,6, Brett D Lindenbach7. 1. Department of the Epidemiology Microbial Diseases, Yale University School of Public Health, New Haven, Connecticut. 2. Department of Anthropology, University of Colorado, Denver. 3. Addiction Research Centre, Utrecht, the Netherlands. 4. Department of Addictology, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, the Czech Republic. 5. Freudenthal Institute for Science and Mathematics Education, Utrecht, the Netherlands. 6. Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut. 7. Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, Connecticut.
Abstract
Background: Controlling hepatitis C virus (HCV) transmission among people who inject drugs (PWID) has focused on preventing sharing syringes and drug preparation paraphernalia, but it is unclear whether HCV incidence linked to sharing paraphernalia reflects contamination of the paraphernalia or syringe-mediated contamination when drugs are shared. Methods: In experiments designed to replicate real-world injection practices when drugs are shared, the residual contents of HCV-contaminated syringes with detachable or fixed needled were passed through the "cookers" and filters used by PWID in preparing drugs for injection and then introduced into a second syringe. All items were tested for the presence of infectious HCV using a chimeric HCV with a luciferase gene. Results: Hepatitis C virus could not be recovered from cookers regardless of input syringe type or cooker design. Recovery was higher when comparing detachable needles to fixed needles for residue in input syringes (73.8% vs 0%), filters (15.4% vs 1.4%), and receptive syringes (93.8% vs 45.7%). Conclusions: Our results, consistent with the hypothesis that sharing paraphernalia does not directly result in HCV transmission but is a surrogate for transmissions resulting from sharing drugs, have important implications for HCV prevention efforts and programs that provide education and safe injection supplies for PWID populations.
Background: Controlling hepatitis C virus (HCV) transmission among people who inject drugs (PWID) has focused on preventing sharing syringes and drug preparation paraphernalia, but it is unclear whether HCV incidence linked to sharing paraphernalia reflects contamination of the paraphernalia or syringe-mediated contamination when drugs are shared. Methods: In experiments designed to replicate real-world injection practices when drugs are shared, the residual contents of HCV-contaminated syringes with detachable or fixed needled were passed through the "cookers" and filters used by PWID in preparing drugs for injection and then introduced into a second syringe. All items were tested for the presence of infectious HCV using a chimeric HCV with a luciferase gene. Results:Hepatitis C virus could not be recovered from cookers regardless of input syringe type or cooker design. Recovery was higher when comparing detachable needles to fixed needles for residue in input syringes (73.8% vs 0%), filters (15.4% vs 1.4%), and receptive syringes (93.8% vs 45.7%). Conclusions: Our results, consistent with the hypothesis that sharing paraphernalia does not directly result in HCV transmission but is a surrogate for transmissions resulting from sharing drugs, have important implications for HCV prevention efforts and programs that provide education and safe injection supplies for PWID populations.
Authors: Tim Rhodes; Merrill Singer; Philippe Bourgois; Samuel R Friedman; Steffanie A Strathdee Journal: Soc Sci Med Date: 2005-03-19 Impact factor: 4.634
Authors: Paul K Nelson; Bradley M Mathers; Benjamin Cowie; Holly Hagan; Don Des Jarlais; Danielle Horyniak; Louisa Degenhardt Journal: Lancet Date: 2011-07-27 Impact factor: 79.321
Authors: Matthew J Akiyama; Charles M Cleland; John A Lizcano; Peter Cherutich; Ann E Kurth Journal: Lancet Infect Dis Date: 2019-09-17 Impact factor: 25.071
Authors: Matthew J Akiyama; Daniel Lipsey; Moonseong Heo; Linda Agyemang; Brianna L Norton; Jennifer Hidalgo; Kiara Lora; Alain H Litwin Journal: Clin Infect Dis Date: 2020-06-10 Impact factor: 9.079
Authors: Jesse L Goldshear; Kelsey A Simpson; Alex H Kral; Lynn D Wenger; Ricky N Bluthenthal Journal: Subst Use Misuse Date: 2021-03-26 Impact factor: 2.362
Authors: Phillip O Coffin; Glenn-Milo Santos; Emily Behar; Jaclyn Hern; John Walker; Tim Matheson; Elizabeth N Kinnard; Janelle Silvis; Eric Vittinghoff; Rena Fox; Kimberley Page Journal: PLoS One Date: 2019-06-03 Impact factor: 3.240
Authors: Yuridia Leyva; Kimberly Page; Stephen Shiboski; Judith A Hahn; Jennifer Evans; Erik Erhardt Journal: Open Forum Infect Dis Date: 2020-03-16 Impact factor: 3.835